USA - NASDAQ:PETS - US7163821066 - Common Stock
The current stock price of PETS is 1.68 USD. In the past month the price decreased by -42.07%. In the past year, price decreased by -64.85%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TSCO | TRACTOR SUPPLY COMPANY | 25.19 | 27.77B | ||
| ULTA | ULTA BEAUTY INC | 18.95 | 22.19B | ||
| DKS | DICK'S SPORTING GOODS INC | 15.03 | 18.86B | ||
| CHWY | CHEWY INC - CLASS A | 94.43 | 14.10B | ||
| FIVE | FIVE BELOW | 26.37 | 8.10B | ||
| BBWI | BATH & BODY WORKS INC | 6.14 | 4.36B | ||
| ASO | ACADEMY SPORTS & OUTDOORS IN | 7.44 | 2.79B | ||
| WRBY | WARBY PARKER INC-CLASS A | 42.94 | 2.09B | ||
| EYE | NATIONAL VISION HOLDINGS INC | 40.84 | 1.97B | ||
| SBH | SALLY BEAUTY HOLDINGS INC | 7.34 | 1.39B | ||
| WINA | WINMARK CORP | 35.89 | 1.43B | ||
| UPBD | UPBOUND GROUP INC | 3.84 | 926.69M |
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 173 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PETMED EXPRESS INC
420 South Congress Avenue
Delray Beach FLORIDA 33445 US
CEO: Menderes Akdag
Employees: 173
Phone: 15614264444
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 173 full-time employees. The company went IPO on 2000-04-06. The firm is an online provider of prescription and non-prescription medications, food, supplements, and supplies and has veterinary and pet insurance service partnerships for dogs, cats, and horses. The company markets and sells directly to consumers through their Websites, toll-free numbers, and employer benefit partnerships. Its product line contains over 15,000 SKUs of pet medications, health products, foods, and supplies. The firm offers various pet supplies, including beds, crates, stairs and other pet supplies. Its products include Prescription Medications (Rx), Non-Prescription Medications (OTC) and supplies, Pet Foods, Private Label and Holistic Wellness Services. Rx includes heartworm and flea and ticks preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
The current stock price of PETS is 1.68 USD. The price decreased by -9.68% in the last trading session.
PETS does not pay a dividend.
PETS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
PETMED EXPRESS INC (PETS) has a market capitalization of 35.31M USD. This makes PETS a Nano Cap stock.
PETMED EXPRESS INC (PETS) will report earnings on 2026-02-09.
The outstanding short interest for PETMED EXPRESS INC (PETS) is 11.44% of its float.
ChartMill assigns a fundamental rating of 3 / 10 to PETS. The financial health of PETS is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months PETS reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.22% | ||
| ROE | -7.37% | ||
| Debt/Equity | 0 |
6 analysts have analysed PETS and the average price target is 2.81 USD. This implies a price increase of 66.96% is expected in the next year compared to the current price of 1.68.
For the next year, analysts expect an EPS growth of 26.23% and a revenue growth -14.05% for PETS